Latent class modeling of repetitive transcranial magnetic stimulation response trajectories in treatment-resistant depression.

This note was surfaced on July 23, 2026. The paper is by Cory Weissman, Brian Cui, Lindsay Benster, Noah Stapper, Jean-Paul Miron, Zafiris Daskalakis, Lawrence Appelbaum, and Jordan Kohn, and it appeared in the Journal of Affective Disorders.

Quick verdict. Useful.

This is a direct clinical heterogeneity paper worth keeping, but the confidence limit matters. This note is based on abstract-only inspection after more than ten full-text attempts. The useful part is not merely that response varies. It is that the paper makes the variation operational as distinct weekly trajectory classes and links the worst class to baseline severity and suicidal-ideation history. Without full text, the class diagnostics, missing-data handling, protocol details, and robustness checks remain partly hidden.

One-paragraph overview.

The paper applies latent class mixture modeling to weekly P H Q 9 scores collected during acute repetitive transcranial magnetic stimulation in 308 treatment-resistant depression patients treated at the U C S D Interventional Psychiatry Program. On the raw scores, the best-fitting solution is a three-class quadratic model: High Baseline, Minimal Improvement; Moderate Baseline, Moderate Improvement; and High Baseline, Large Improvement. The large-improvement class shows the strongest symptom reduction and response rate, while baseline severity plus suicidal-ideation history point toward the worst trajectory. A baseline-adjusted sensitivity analysis collapses the picture to a two-class moderate-versus-large-improvement solution, and a lasso-penalized multinomial model reportedly reaches multi-class A U C of 0.82. The practical claim is that some patients look identifiable as likely nonresponders early enough that alternative interventions should be considered sooner rather than after a full disappointing course.

Now the model definition.

Inputs.

Weekly P H Q 9 depression scores collected during acute r T M S treatment, plus baseline clinical features used to predict trajectory-class membership.

Outputs.

Latent response-trajectory classes over the acute treatment course, class-specific symptom-improvement patterns, and predicted odds of class membership from baseline clinical variables.

Training objective, or loss.

The exact likelihood formulation and penalty details are not available from the accessible abstract text. The paper reports latent class mixture modeling on longitudinal P H Q 9 trajectories plus lasso-penalized multinomial logistic regression with nested cross-validation for class prediction.

Architecture and parameterization.

A three-class quadratic latent class mixture model for raw P H Q 9 trajectories, a two-class baseline-adjusted sensitivity model, and a lasso-penalized multinomial classifier for baseline predictor analysis.

Now the key questions.

First, what problem is the paper trying to solve?

Average end-of-treatment response rates hide the fact that acute r T M S patients do not all improve along the same path. The paper tries to identify distinct response trajectories so clinicians can reason about early nonresponse rather than waiting for the whole course to fail.

Second, what is the method?

The authors fit latent class mixture models to weekly P H Q 9 scores during acute r T M S treatment, then use lasso-penalized multinomial logistic regression with nested cross-validation to predict class membership from baseline clinical variables.

Third, what is the method motivation?

If r T M S response heterogeneity has stable trajectory structure, then treatment triage should focus on class membership and early divergence rather than only on final average symptom change.

Fourth, what data does it use?

The accessible abstract reports 308 patients with treatment-resistant depression treated in the U C S D Interventional Psychiatry Program, with weekly P H Q 9 measurements collected during acute r T M S treatment.

Fifth, how is it evaluated?

Evaluation in the accessible abstract consists of latent-class model selection on raw and baseline-adjusted trajectories, plus nested-cross-validated multi-class discrimination for baseline predictors.

Sixth, what are the main results?

The raw-score analysis favors a three-class quadratic solution: High Baseline, Minimal Improvement; Moderate Baseline, Moderate Improvement; and High Baseline, Large Improvement.

The large-improvement class reportedly shows 65.5 percent symptom reduction and an 84 percent response rate.

The baseline-adjusted sensitivity analysis yields a simpler two-class moderate-versus-large-improvement solution.

Predictive modeling reaches A U C 0.82.

History of suicidal ideation is associated with higher odds of the worst class, while tobacco use and no previous suicide attempt are associated with the large-improvement class.

Seventh, what is actually novel?

The novelty is not that r T M S outcomes vary. The useful novelty is treating weekly symptom curves as explicit latent trajectory classes and tying those classes to baseline predictors that could matter for early intervention switching.

Eighth, what are the strengths?

The cohort is reasonably large for a single-program interventional-psychiatry dataset.

The paper uses weekly longitudinal symptom data rather than only baseline and endpoint snapshots.

The trajectory framing is more clinically actionable than generic response-versus-nonresponse rhetoric.

The predictive analysis at least tries to move from description toward triage.

Ninth, what are the weaknesses, limitations, or red flags?

This note is based on abstract-only inspection after more than ten full-text attempts, so the model diagnostics, class-separation quality, missing-data strategy, and protocol specifics are not visible.

The cohort comes from one interventional-psychiatry program, so transportability is unearned.

The analysis appears centered on P H Q 9 trajectories rather than richer state, biomarker, or circuit measures.

The tobacco-use and prior-suicide-attempt findings may reflect confounding or site-specific clinical structure rather than robust biology.

Tenth, what challenges or open problems remain?

The main open problems are external validation, earlier decision thresholds during the course itself, linkage to physiological or circuit-level biomarkers, and testing whether trajectory-informed switching actually improves patient outcomes.

Eleventh, what future work naturally follows?

Prospective multisite replication, integration with E E G or T M S-response biomarkers, explicit early-switch decision rules, and treatment-assignment studies that ask whether likely high-baseline minimal-improvement patients should move sooner to alternative interventions such as esketamine, accelerated protocols, or combination strategies.

Twelfth, why does this matter for cabbageland?

Because precision neuromodulation needs better objects than mean endpoint change. If some patients enter a recognizable high-baseline minimal-improvement lane early, that should change triage logic, study design, and how biomarker papers define the target they are trying to predict.

Thirteenth, what ideas are steal-worthy?

Treat longitudinal symptom response as a latent-class problem rather than a single scalar endpoint.

Use class membership as the clinical object that biomarker and stimulation-parameter papers should try to predict.

Frame early nonresponse as a trigger for treatment reassignment rather than a passive observation at week six.

Fourteenth, final decision.

Keep as a useful clinical heterogeneity note, but with explicit confidence limits. The trajectory framing is valuable. The paper just has not yet earned full-trust status here because the preserved note rests on abstract-only inspection after more than ten full-text attempts.
